2 terminated. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Terminated 2 |
Follow Childhood Diffuse Large Cell Lymphoma: new trials by email Literature Review of Childhood Diffuse Large Cell Lymphoma trials Research Report on Childhood Diffuse Large Cell Lymphoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Obatoclax Mesylate, Vincristine Sulfate, Doxorubicin Hydrochloride, and Dexrazoxane Hydrochloride in Treating Young Patients With Relapsed or Refractory Solid Tumors, Lymphoma, or Leukemia dexrazoxane hydrochloride, doxorubicin hydrochloride, obatoclax mesylate - Acute Leukemias of Ambiguous Lineage, Acute Undifferentiated Leukemia | Phase 1 | Terminated | National Cancer Institute (NCI) | 22 | 2009-06-01 | 2014-05-01 |
| Oxaliplatin, Ifosfamide and Etoposide in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma oxaliplatin, etoposide - Angioimmunoblastic T-cell Lymphoma, B-cell Childhood Acute Lymphoblastic Leukemia | Phase 1 | Terminated | National Cancer Institute (NCI) | 40 | 2004-11-01 | 2014-02-24 |
Burkitt Lymphoma (2) · Dendritic Cell Sarcoma, Interdigitating (2) · Immunoblastic Lymphadenopathy (2) · Intraocular Lymphoma (2) · Leukemia, Hairy Cell (2) · Leukemia, Lymphocytic, Chronic, B-Cell (2) · Lymphoma, Extranodal NK-T-Cell (2) · Lymphoma, Large B-Cell, Diffuse (2) · Lymphoma, Large-Cell, Anaplastic (2) · Lymphoma, T-Cell, Cutaneous (2) · Lymphoma, T-Cell, Peripheral (2) · Mycosis Fungoides (2) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (2) · Recurrence (2) · Sezary Syndrome (2)
Chronic Disease (2) · DNA Virus Infections (2) · Disease Attributes (2) · Epstein-Barr Virus Infections (2) · Eye Neoplasms (2) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Herpesviridae Infections (2) · Histiocytic Disorders, Malignant (2) · Histiocytosis (2) · Immune System Diseases (2) · Immunoproliferative Disorders (2) · Infections (2) · Leukemia (2) · Leukemia, B-Cell (2)
Dexrazoxane (1) · Doxorubicin (1) · Etoposide (1) · Oxaliplatin (1) · Razoxane (1) · Vincristine (1) · obatoclax (1)
National Cancer Institute (NCI) (2)
United States (2) · Canada (1)
Lisa McGregor (1) · Richard Aplenc (1)
P30CA021765 (1), U01CA097452 (1)